- Home
- PRAX vs NRDS Comparison
PRAX vs NRDS Comparison
Compare PRAX & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRAX | NRDS |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 1.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRAX | NRDS |
|---|---|---|
| Price | $282.69 | $14.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $349.79 | $15.40 |
| AVG Volume (30 Days) | ★ 1.0M | 889.0K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $7,463,000.00 | ★ $795,000,000.00 |
| Revenue This Year | N/A | $22.09 |
| Revenue Next Year | N/A | $7.18 |
| P/E Ratio | ★ N/A | $15.40 |
| Revenue Growth | ★ 364.98 | 24.71 |
| 52 Week Low | $26.70 | $7.55 |
| 52 Week High | $282.99 | $16.24 |
Technical Indicators
Market Signals| Indicator | PRAX | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 71.90 | 50.00 |
| Support Level | $262.31 | $14.22 |
| Resistance Level | $282.99 | $15.13 |
| Average True Range (ATR) | 16.62 | 0.54 |
| MACD | 1.60 | -0.17 |
| Stochastic Oscillator | 97.86 | 29.29 |
Price Performance
Historical ComparisonAbout PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.